<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/23454317-ADC4-4369-A212-BF0802191E59"><gtr:id>23454317-ADC4-4369-A212-BF0802191E59</gtr:id><gtr:name>Domainex</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>National Heart and Lung Institute</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/23454317-ADC4-4369-A212-BF0802191E59"><gtr:id>23454317-ADC4-4369-A212-BF0802191E59</gtr:id><gtr:name>Domainex</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/826273D7-CE6F-46DF-ACD7-5FBFB3745FDC"><gtr:id>826273D7-CE6F-46DF-ACD7-5FBFB3745FDC</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:otherNames>David</gtr:otherNames><gtr:surname>Schneider</gtr:surname><gtr:orcidId>0000-0001-9645-1938</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C9DEB329-8887-4F15-9405-9DF482094D57"><gtr:id>C9DEB329-8887-4F15-9405-9DF482094D57</gtr:id><gtr:firstName>Nadia</gtr:firstName><gtr:surname>Rosenthal</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A4266D27-E06B-4884-967D-643864274C6E"><gtr:id>A4266D27-E06B-4884-967D-643864274C6E</gtr:id><gtr:firstName>Timothy</gtr:firstName><gtr:surname>Aitman</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5B6834E3-C96A-4C2C-8722-FC2F29748C31"><gtr:id>5B6834E3-C96A-4C2C-8722-FC2F29748C31</gtr:id><gtr:firstName>Jesus</gtr:firstName><gtr:surname>Gil</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5412D979-6674-4B69-91D6-38D8EC2F5C41"><gtr:id>5412D979-6674-4B69-91D6-38D8EC2F5C41</gtr:id><gtr:firstName>Amanda</gtr:firstName><gtr:otherNames>G</gtr:otherNames><gtr:surname>Fisher</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B1275E81-B800-4556-9E4B-F729383AE5BB"><gtr:id>B1275E81-B800-4556-9E4B-F729383AE5BB</gtr:id><gtr:firstName>Ana</gtr:firstName><gtr:surname>Pombo</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/8757FBA7-07CE-4F4E-9510-AEBCDBE73724"><gtr:id>8757FBA7-07CE-4F4E-9510-AEBCDBE73724</gtr:id><gtr:firstName>Sian</gtr:firstName><gtr:otherNames>E</gtr:otherNames><gtr:surname>Harding</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/40D6088C-0CEE-4BD5-A0F3-0F81B0899793"><gtr:id>40D6088C-0CEE-4BD5-A0F3-0F81B0899793</gtr:id><gtr:firstName>Stuart</gtr:firstName><gtr:surname>Cook</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0901467"><gtr:id>3058EC10-8F54-4E69-837A-CF4AB9BE585A</gtr:id><gtr:title>MRC-BHF Cardiovascular Stem Cell Research Strategic Development Grant</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0901467</gtr:grantReference><gtr:abstractText>Heart muscle does not grow back following a heart attack. For this reason, a stem cell approach to regenerate the heart is attractive. We focus on using embryonic stem cells (primitive cells with the ability to become every cell type desired) or a rare and unexpected stem cell we discovered, which exists in heart muscle itself. These experiments are aimed at solving several fascinating and important problems. Where do these cardiac stem cells come from during life, and what do they become in healthy and diseased hearts? Can we improve their number or function to enhance the repair and regeneration of the heart? What specific genes and connections of genes control cardiac muscle creation? Using advanced robotic methods that test hundreds or thousands of conditions, and advanced genetic methods that measure every gene in the cells, we will study which genes are active in heart-forming cells and which are important for the cells function.</gtr:abstractText><gtr:technicalSummary>In humans and other mammals, the inability of adult myocardium to overcome cell death with equivalent muscle cell creation makes heart muscle cell number unusually well-posed as a therapeutic target. Notwithstanding a few exemplars, the clinical aspirations arising from this biological limit have led to a plethora of largely repetitive empirical trials with weak outcomes overall, little proven impact on myocyte formation and, typically, weak scientific underpinnings. The need is unequivocal for better, deeper, more systematic knowledge?including genomic, post-genomic and functional characterization of relevant cardiopoietic cells, if a step change is ever to occur in progress towards cardiac regeneration as a workable clinical goal. Inherently, the problem requires a team-based or consortium approach, as is sought by the present MRC-BHF call. This Cardiovascular Stem Cell Research Strategic Development Grant at Imperial College London is a coordinated effort of the National Heart and Lung Institute (NHLI) headed by Professor Michael Schneider FMedSci, an innovative pioneer in cardiovascular stem cell biology, and the MRC Clinical Sciences Centre (CSC) headed by Professor Amanda Fisher FMedSci, a distinguished authority on stem cell epigenetics. Members of the proposed Cardiovascular Stem Cell Research Strategic Development Grant include key experts in mouse genetics, genomics and epigenetics, focused collectively on a series of essential fundamental problems: (1) fate-mapping to define the embryological origin of cardiac progenitor cells and their subsequent contribution to the heart in health and disease; (2) sirtuins and insulin-like growth factor-1 as epigenetic modulators of cardiac repair; (3) chromatin profiling and epigenetic reprogramming of cardiac progenitor cells; (4) high-throughput high-content analyses of cardiac progenitor cell differentiation and function; and (5) next-generation genomics for gene, pathway and chromatin studies in cardiac progenitor cells. A 6,0000 m2 Cardiovascular Research Centre is under construction at Imperial?s Hammersmith campus, adjacent to expanded MRC facilities, and a highly robust recruitment drive is already underway. Apart from the specific questions to be addressed, the overriding goal of this proposal is alignment, integration and capacity-building, establishing an internationally competitive cardiovascular stem cell community that would help lead UK science in this realm and warrant a full-scale Centre in three years? time.</gtr:technicalSummary><gtr:fund><gtr:end>2014-05-16</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-01-17</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1016391</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Dundee</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Protein Phosphorylation and Ubiquitylation Unit</gtr:department><gtr:description>Novel small molecule inhibitors of MAP4K4 to suppress cardiac muscle cell death</gtr:description><gtr:id>F4BEA7CB-7E8D-41A7-B8BD-DEF3B4ECAF06</gtr:id><gtr:impact>Cardiovascular biology, chemical biology, clinical cardiology, medicinal chemistry, molecular and cellular biology, molecular physiology</gtr:impact><gtr:outcomeId>5461dda4ef0963.63623814-2</gtr:outcomeId><gtr:partnerContribution>MRC Protein Phosphorylation Unit: Kinase selectivity profiling

Domainex: Medicinal chemistry strategy, docking model, computer-assisted drug design, current site for cell free assays, partner organisation for the successful &amp;pound;2.5M Wellcome Trust Early Stage Seeding Drug Discovery Award</gtr:partnerContribution><gtr:piContribution>My laboratory identified MAP4K4 (an upstream member of the MAP kinase superfamily) as a potential nodal control point for cardiac muscle cell death, based on (1) biochemical analyses of severe human heart failure, four mouse models of heart disease, and cultured cardiomyocytes subjected to four specific death signals; (2) gain-of-function mutations in mouse myocardium and cultured cardiomyocytes, which potentiate or suffice to drive cell death; (3) dominant-negative mutations and RNA interference in cultured cardiomyocytes, which confer significant protection from cell death. Together with colleagues in Imperial's Drug Discovery Centre, we initiated cell-free screens for novel inhibitors of MAP4K4, through 3D field-point modelling of features conserved among the seemingly unrelated primary hits. The field point model was used to screen 3.7 million structures in silica, 45 compounds were tested against human MAP4K4.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Domainex</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Novel small molecule inhibitors of MAP4K4 to suppress cardiac muscle cell death</gtr:description><gtr:id>D6D3E50D-0A53-4BE4-A125-6F71A25F5077</gtr:id><gtr:impact>Cardiovascular biology, chemical biology, clinical cardiology, medicinal chemistry, molecular and cellular biology, molecular physiology</gtr:impact><gtr:outcomeId>5461dda4ef0963.63623814-1</gtr:outcomeId><gtr:partnerContribution>MRC Protein Phosphorylation Unit: Kinase selectivity profiling

Domainex: Medicinal chemistry strategy, docking model, computer-assisted drug design, current site for cell free assays, partner organisation for the successful &amp;pound;2.5M Wellcome Trust Early Stage Seeding Drug Discovery Award</gtr:partnerContribution><gtr:piContribution>My laboratory identified MAP4K4 (an upstream member of the MAP kinase superfamily) as a potential nodal control point for cardiac muscle cell death, based on (1) biochemical analyses of severe human heart failure, four mouse models of heart disease, and cultured cardiomyocytes subjected to four specific death signals; (2) gain-of-function mutations in mouse myocardium and cultured cardiomyocytes, which potentiate or suffice to drive cell death; (3) dominant-negative mutations and RNA interference in cultured cardiomyocytes, which confer significant protection from cell death. Together with colleagues in Imperial's Drug Discovery Centre, we initiated cell-free screens for novel inhibitors of MAP4K4, through 3D field-point modelling of features conserved among the seemingly unrelated primary hits. The field point model was used to screen 3.7 million structures in silica, 45 compounds were tested against human MAP4K4.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>AZ CSC screen</gtr:description><gtr:id>A66EC1B2-C1E7-47BF-99A3-296342C6FC17</gtr:id><gtr:impact>Not as yet</gtr:impact><gtr:outcomeId>569f8d40098cd1.83752641-1</gtr:outcomeId><gtr:partnerContribution>Provision of a well-characterised and annotated compound library, including proprietary agents; shared information and technical advice</gtr:partnerContribution><gtr:piContribution>Evaluating compounds and pathways for driving the differentiation of dormant stem cells purified from adult mouse myocardium; unique cells and assay methods</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Annual Clinical School Lecture, Cambridge Medical Society, Addenbrooks Hospital, Cambridge</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>0ABD0E63-0076-4856-9202-FBAA431550C1</gtr:id><gtr:impact>50 Cambridge alumni and partners attended lecture, with lively discussion afterwards

not reported</gtr:impact><gtr:outcomeId>LoJtWmxfupN</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture to the Friends of Imperial (&quot;The Self-healing Heart&quot;)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>06140497-C57F-47D6-B44A-86B8A829D44D</gtr:id><gtr:impact>Thirty lay adults attended an evening behind the scenes in Imperial's cardiovascular laboratories, preceded by a lecture on cardiac regeneration and stem cell biology.</gtr:impact><gtr:outcomeId>537b46b0144eb1.38153103</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>RCUK Research, Innovate, Grow event (Westminster)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>ACEE6808-A354-4FC7-93E2-DAFAA868726A</gtr:id><gtr:impact>Presented the MRC Regenerative Medicine programme to BIS Minister Jo Johnson, business leaders, entrepreneurs, world-leading researchers, parliamentarians and policymakers, as part of a Research Councils UK event</gtr:impact><gtr:outcomeId>56d956762cd585.44963239</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:url>http://www.rcuk.ac.uk/rig/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Podcast (Understanding Animal Research)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B1C56159-8C77-4648-9F26-9EEFD32E55B2</gtr:id><gtr:impact>online interview

not known</gtr:impact><gtr:outcomeId>537b4aca44cfb4.43953020</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.understandinganimalresearch.org.uk/resources/video-library/24/stem-cells-and-heart-repair/</gtr:url><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BHF Supporters Day (London)</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>AEC939F9-2170-48BD-99A1-32ACF70CAC52</gtr:id><gtr:impact>Hosted and lectured at the regional annual South of England symposium for BHF supporters</gtr:impact><gtr:outcomeId>58a1e0735aaf86.24515632</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:url>https://www.bhf.org.uk/get-involved/in-your-area/supporter-conferences</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Newspaper article - The Times (&quot;A question of visas and world talent&quot;)</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7D3EEA0F-3495-4F95-A713-68C4ABDF0A49</gtr:id><gtr:impact>Circulation 508K

Not known</gtr:impact><gtr:outcomeId>537b4710c1b9c4.74163977</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Daily Mail interview (&quot;Jab that can trick the heart into healing itself could be given to coronary victims in back of ambulances&quot;)</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>56AFD889-2602-4666-A59B-86BE0704D4CF</gtr:id><gtr:impact>Was interviewed by Fiona Macrae about our work on dormant stem cells in adult heart tissue

Circulation 1.9M; 203 &amp;quot;likes&amp;quot; on Facebook</gtr:impact><gtr:outcomeId>PVvXtNDGRYH</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.dailymail.co.uk/health/article-2207630/The-jab-trick-heart-heal-itself.html</gtr:url><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science in Store (Ealing)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F7EC9877-C600-4546-8221-99F147D14E4B</gtr:id><gtr:impact>Simple play-oriented science demonstration about heart muscle cell structure and electrical connectivity, for primary-school-age children and families. This successful activity module is being disseminated to other public engagement activities. Discussion/Q&amp;amp;A with parents, patients.</gtr:impact><gtr:outcomeId>58a1df60879e79.61459594</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.bhf.org.uk/get-involved/events/social-events/science-in-store</gtr:url><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>iTunes video interview - Imperial</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BB6603A4-E85D-4EB7-98FC-5174489C759E</gtr:id><gtr:impact>Online interview on cardiac stem cell biology &amp;amp; regenerative medicine. Available through iTunes.

Not known</gtr:impact><gtr:outcomeId>537b458d194d00.76955029</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Recurring lay visits</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>A194447F-663B-4786-BBC8-B404A14E6D10</gtr:id><gtr:impact>Recurring visits of potential high-value British Heart Foundation donors, in support of the Mending Broken Hearts capital campaign

BHF reports lay visitor enthusiasm and appreciation for regenerative medicine initiative</gtr:impact><gtr:outcomeId>JX7kok9k7Bu</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011,2012,2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Online webcast and transcript (House of Lords Select Committee on Science and Technology Inquiry on Regenerative Medicine)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BA1BB191-86B1-4372-BB4C-2B8065766445</gtr:id><gtr:impact>online webcast and transcript

Contributed to the resulting House of Lords Select Committee Report on Regenerative Medicine (2013)</gtr:impact><gtr:outcomeId>537b4c27c6df79.48989140</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Online chatroom (Heart Zone, imascientist.org.uk)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2468599E-F1E4-4F95-A686-E176D826007D</gtr:id><gtr:impact>stimulated active Q&amp;amp;A with diverse student groups

Organisers were pleased with the level of student animation by the sessions and sought my further involvement for future activities.</gtr:impact><gtr:outcomeId>56939bbc15c835.33918397</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:url>http://imascientist.org.uk</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>3000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Centre of Research Excellence</gtr:description><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>RE/08/002 (renewal)</gtr:fundingRef><gtr:id>85E0A263-A831-4188-901C-5A3A4BC0B688</gtr:id><gtr:outcomeId>Fr3e7AJrRGB</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Early Stage Seeding Drug Discovery Grant</gtr:description><gtr:end>2017-02-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>WT106328</gtr:fundingRef><gtr:id>D350A647-AAD7-4E71-9B33-7339B7B844DE</gtr:id><gtr:outcomeId>5461dea3089d28.44910874</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UK Cardiovascular Regenerative Medicine Centre</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>RM/13/1/30157</gtr:fundingRef><gtr:id>1907FC91-B502-4648-ACAC-7780D513A98B</gtr:id><gtr:outcomeId>nF7faioXcBT</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>9740780</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Imperial Biomedical Research Centre</gtr:department><gtr:description>Cardiovascular Biomedical Research Unit</gtr:description><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>02152530-AC0A-4641-8AA4-A0B0289F5100</gtr:id><gtr:outcomeId>hzETrK15UyL0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3316082</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NIHR Imperial Biomedical Research Centre</gtr:department><gtr:description>Comprehensive Biomedical Research Centre - Cardiovascular Theme</gtr:description><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>5C206989-B61C-4251-AED6-C3FA55B5CE6F</gtr:id><gtr:outcomeId>KEFVUM6Z8W50</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>4-Year PhD Studentship Scheme</gtr:description><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>FB93503F-A479-48D6-8F4C-256E063CCCA7</gtr:id><gtr:outcomeId>537b43abe28729.00476303</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Strategic Initiative - Funds toward building and equipping the Hammersmith Campus L Block facility, Imperial College London</gtr:description><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>SI/11/2/28875</gtr:fundingRef><gtr:id>3E72948C-CCD0-42AC-8DA3-92FBAE524576</gtr:id><gtr:outcomeId>nyAkWfrw46c0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>4500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Late Stage Seeding Drug Discovery Award</gtr:description><gtr:end>2019-11-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>205256/Z/16/Z</gtr:fundingRef><gtr:id>57077C05-BE38-42D8-A9C1-AC460103F49F</gtr:id><gtr:outcomeId>58a1dc4cc75cd6.68383116</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>78403</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Confidence in Concepts Fund</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>CiC 2012 (MC_PC_12015)</gtr:fundingRef><gtr:id>637A800E-AACB-427C-821C-595A82495F9F</gtr:id><gtr:outcomeId>HpcdjXi5xJT</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member, MRC Council</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DD86A931-4C38-43DA-9DF5-FC65750BB3DC</gtr:id><gtr:outcomeId>EKfGMK1v2MV</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>House of Lords Science and Technology Inquiry on Regenerative Medicine</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A2D72D62-C7C9-4990-9566-7C46AC717818</gtr:id><gtr:outcomeId>Q8PfDHDvkd1</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member, Technology Strategy Board-MRC-EPSRC-BBSRC Advisory Group on Regenerative Medicine (RegenMed)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DE89DE9B-3BE3-45ED-9805-978958D76E78</gtr:id><gtr:impact>Led to the funding of multiple industry-led projects in regenerative medicine, as well as to the overall UK Strategy for Regenerative Medicine</gtr:impact><gtr:outcomeId>fJKWAjZKVJc</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Highly specific small molecular inhibitors of MAP4K4 that suppress cardiac muscle cell death</gtr:description><gtr:id>70414AEE-E19C-49E0-9C58-3E056CBE2352</gtr:id><gtr:impact>The inhibitors of MAP4K4 suppress human cardiac muscle cell death, using induced pluripotent cell-derived cardiomyocytes.</gtr:impact><gtr:outcomeId>537b55c230c017.88537855</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Novel inhibitors of MAP4K4</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://www3.imperial.ac.uk/newsandeventspggrp/imperialcollege/newssummary/news_13-4-2015-12-55-43</gtr:url></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Novel adult cardiac stem cell lines generated from Sca-1+ side population cells, Sca-1+ PDGFRa+ cells, and other sub-populations</gtr:description><gtr:id>3B643408-142F-4574-83C4-34B7E71643D7</gtr:id><gtr:impact>Demonstration that physical substrate affects nuclear histone deactylase content in cardiac stem cells (with materials scientist Molly Stevens, Imperial Faculty of Engineering)

Demonstration of epigenetic mechanisms affecting the cardiac cell fate in cardiac stem cells (DNA methylation: with Tim Aitman, MRC CSC; histone marks and RNA-Seq, with Ana Pombo, MRC CSC)

Demonstration that the cardiac stem cells can rescue human stem cell-derived cardiomyocytes from lethal oxidative stress, via secreted signals. Global transcriptomic and proteomic studies are in progress. Interim studies of several dozen candidate factors have identified roughly a half dozen whose presence correlates strongly with the observed cardiac muscle cell protection.

Demonstration that the cardiac stem cells can suppress M1 macrophage polarisation and promote M2 macrophage polarisation, via secreted signals.</gtr:impact><gtr:outcomeId>dQBoK2xKHM8</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Cardiac stem cell lines</gtr:title><gtr:type>Cell line</gtr:type><gtr:url>https://www.bhf.org.uk/news-from-the-bhf/news-archive/2015/may/stem-cell-injection</gtr:url><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>BB1A85F7-FB92-47B7-914E-128A18266ACA</gtr:id><gtr:title>Intravenous delivery of adeno-associated virus 9-encoded IGF-1Ea propeptide improves post-infarct cardiac remodelling.</gtr:title><gtr:parentPublicationTitle>NPJ Regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18fa3f25461794c249e68c40543d0dc4"><gtr:id>18fa3f25461794c249e68c40543d0dc4</gtr:id><gtr:otherNames>Gallego-Colon E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2057-3995</gtr:issn><gtr:outcomeId>5a6ef2aea59dd7.88524983</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5B33078-6F9A-4E18-A49D-00490A570063</gtr:id><gtr:title>Modulation of human embryonic stem cell-derived cardiomyocyte growth: a testbed for studying human cardiac hypertrophy?</gtr:title><gtr:parentPublicationTitle>Journal of molecular and cellular cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44f93743e559aafdfa1e2921addae87e"><gtr:id>44f93743e559aafdfa1e2921addae87e</gtr:id><gtr:otherNames>F?ldes G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-2828</gtr:issn><gtr:outcomeId>pm_13314_24_21047517</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BEBB1707-B6D5-45BE-926D-5CE34B30E68C</gtr:id><gtr:title>The Quest for the Adult Cardiac Stem Cell.</gtr:title><gtr:parentPublicationTitle>Circulation journal : official journal of the Japanese Circulation Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69f683a0294f8623647160e859318df6"><gtr:id>69f683a0294f8623647160e859318df6</gtr:id><gtr:otherNames>Noseda M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1346-9843</gtr:issn><gtr:outcomeId>5675e676ce051</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5FA8A4BF-E5AA-4E64-B0F8-8D88C2B82DF2</gtr:id><gtr:title>Complete cardiac regeneration in a mouse model of myocardial infarction.</gtr:title><gtr:parentPublicationTitle>Aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/941f961ae2e046ba86444ef3b3298a65"><gtr:id>941f961ae2e046ba86444ef3b3298a65</gtr:id><gtr:otherNames>Haubner BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1945-4589</gtr:issn><gtr:outcomeId>pm_13314_24_23425860</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9FB3408-AD1C-42AB-AEE0-E833804DF564</gtr:id><gtr:title>Development of high content imaging methods for cell death detection in human pluripotent stem cell-derived cardiomyocytes.</gtr:title><gtr:parentPublicationTitle>Journal of cardiovascular translational research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9230597ccd0ddd72fdd49d9010c54335"><gtr:id>9230597ccd0ddd72fdd49d9010c54335</gtr:id><gtr:otherNames>Mioulane M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1937-5387</gtr:issn><gtr:outcomeId>pm_13314_24_22896035</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2FBCAE30-12A2-495A-9938-0730A288F7E4</gtr:id><gtr:title>PDGFRa demarcates the cardiogenic clonogenic Sca1+ stem/progenitor cell in adult murine myocardium.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69f683a0294f8623647160e859318df6"><gtr:id>69f683a0294f8623647160e859318df6</gtr:id><gtr:otherNames>Noseda M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5675e49411f68</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D4451DE-33C5-422E-A009-2DE953B67589</gtr:id><gtr:title>Folliculin (Flcn) inactivation leads to murine cardiac hypertrophy through mTORC1 deregulation.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/027af27f4706d9dbed735f6af61d6348"><gtr:id>027af27f4706d9dbed735f6af61d6348</gtr:id><gtr:otherNames>Hasumi Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>5461d96c993608.20365726</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4A213D2-0B92-4B2A-92AA-CF324998170B</gtr:id><gtr:title>Forward Programming of Cardiac Stem Cells by Homogeneous Transduction with MYOCD plus TBX5.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2b5279243c914b47d40d4df092c0e6e9"><gtr:id>2b5279243c914b47d40d4df092c0e6e9</gtr:id><gtr:otherNames>Belian E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5675e5f10a5c5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FFBAD47C-8A1F-4196-91E5-FE6B8E5D8D17</gtr:id><gtr:title>Heartbreak hotel: a convergence in cardiac regeneration.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/96375628b1a48c9dceb02c56e7ac1aff"><gtr:id>96375628b1a48c9dceb02c56e7ac1aff</gtr:id><gtr:otherNames>Schneider MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn><gtr:outcomeId>585d4e3d49d595.05895596</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2039EBD7-3DA0-4979-83C7-65B542AF84DC</gtr:id><gtr:title>Mutations in CDK5RAP2 cause Seckel syndrome.</gtr:title><gtr:parentPublicationTitle>Molecular genetics &amp; genomic medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f712c3e9c7aa3cef8e07c25874d5b84d"><gtr:id>f712c3e9c7aa3cef8e07c25874d5b84d</gtr:id><gtr:otherNames>Yigit G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2324-9269</gtr:issn><gtr:outcomeId>58b44183082a82.20548898</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C68DE51-4634-4C15-8404-A309D3EF0DB4</gtr:id><gtr:title>Cardiopoietic factors: extracellular signals for cardiac lineage commitment.</gtr:title><gtr:parentPublicationTitle>Circulation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69f683a0294f8623647160e859318df6"><gtr:id>69f683a0294f8623647160e859318df6</gtr:id><gtr:otherNames>Noseda M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0009-7330</gtr:issn><gtr:outcomeId>EhL64spx2mg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D4E190D-9923-42E2-95A0-BE7BA98FD0AD</gtr:id><gtr:title>Systemic autoimmunity induced by the TLR7/8 agonist Resiquimod causes myocarditis and dilated cardiomyopathy in a new mouse model of autoimmune heart disease.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0a9e4cfa1532194c84e450166c01297"><gtr:id>d0a9e4cfa1532194c84e450166c01297</gtr:id><gtr:otherNames>Hasham MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>5a6f062a0015e9.94494709</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62D794D5-D4CD-48EF-A638-C77047D26E40</gtr:id><gtr:title>T1 mapping detects pharmacological retardation of diffuse cardiac fibrosis in mouse pressure-overload hypertrophy.</gtr:title><gtr:parentPublicationTitle>Circulation. Cardiovascular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/feb64d6405c8d7955872aa45e2535e08"><gtr:id>feb64d6405c8d7955872aa45e2535e08</gtr:id><gtr:otherNames>Stuckey DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1941-9651</gtr:issn><gtr:outcomeId>pm_13314_24_24425501</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9361DAC-28EE-40AF-AF35-53A116FB2EA1</gtr:id><gtr:title>P595PDGFRalpha demarcates the cardiogenic and clonogenic Sca-1+ stem cell</gtr:title><gtr:parentPublicationTitle>Cardiovascular Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69f683a0294f8623647160e859318df6"><gtr:id>69f683a0294f8623647160e859318df6</gtr:id><gtr:otherNames>Noseda M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>537b54572ca1d9.48439242</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9137C92-6206-4F5A-A16D-C07C55520672</gtr:id><gtr:title>Enhanced efficiency of genetic programming toward cardiomyocyte creation through topographical cues.</gtr:title><gtr:parentPublicationTitle>Biomaterials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4156357cec432e78000138b12e51a767"><gtr:id>4156357cec432e78000138b12e51a767</gtr:id><gtr:otherNames>Morez C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0142-9612</gtr:issn><gtr:outcomeId>569394ab5dfc79.50505224</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CEED7DF2-F62F-46D2-9AC0-F7DFF3D34CCA</gtr:id><gtr:title>Immunosuppressive agents modulate function, growth, and survival of cardiomyocytes and endothelial cells derived from human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44f93743e559aafdfa1e2921addae87e"><gtr:id>44f93743e559aafdfa1e2921addae87e</gtr:id><gtr:otherNames>F?ldes G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1547-3287</gtr:issn><gtr:outcomeId>pm_13314_24_24192059</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76F73C72-F54F-484C-872F-95336B85C7D9</gtr:id><gtr:title>Cardiac muscle regeneration: lessons from development.</gtr:title><gtr:parentPublicationTitle>Genes &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcee5ab95f4d1679b318e5b722aceba1"><gtr:id>bcee5ab95f4d1679b318e5b722aceba1</gtr:id><gtr:otherNames>Mercola M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0890-9369</gtr:issn><gtr:outcomeId>javdmPxh7KB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9629FD53-6A78-4B4E-A895-C30B2165736A</gtr:id><gtr:title>Monocyte/Macrophage-derived IGF-1 Orchestrates Murine Skeletal Muscle Regeneration and Modulates Autocrine Polarization.</gtr:title><gtr:parentPublicationTitle>Molecular therapy : the journal of the American Society of Gene Therapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7267c4f5d5a7ee634d8d242a861ce1b"><gtr:id>b7267c4f5d5a7ee634d8d242a861ce1b</gtr:id><gtr:otherNames>Tonkin J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1525-0016</gtr:issn><gtr:outcomeId>5a6ef27a5b9707.23622764</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46F0CC10-D4E2-4244-A222-9ED3E31D8A7D</gtr:id><gtr:title>ZBTB17 (MIZ1) Is Important for the Cardiac Stress Response and a Novel Candidate Gene for Cardiomyopathy and Heart Failure.</gtr:title><gtr:parentPublicationTitle>Circulation. Cardiovascular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bf438be6478ad24108ae9b912c067249"><gtr:id>bf438be6478ad24108ae9b912c067249</gtr:id><gtr:otherNames>Buyandelger B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1942-3268</gtr:issn><gtr:outcomeId>569394ab82f529.40602663</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8BEFFFE8-40DB-474C-B6E3-C87B9BA6629D</gtr:id><gtr:title>Cardiac-Restricted IGF-1Ea Overexpression Reduces the Early Accumulation of Inflammatory Myeloid Cells and Mediates Expression of Extracellular Matrix Remodelling Genes after Myocardial Infarction.</gtr:title><gtr:parentPublicationTitle>Mediators of inflammation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18fa3f25461794c249e68c40543d0dc4"><gtr:id>18fa3f25461794c249e68c40543d0dc4</gtr:id><gtr:otherNames>Gallego-Colon E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0962-9351</gtr:issn><gtr:outcomeId>569394aac69872.58191679</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33CD9C66-5CDC-4FC9-B439-8789DC94222F</gtr:id><gtr:title>Hhex and Cer1 mediate the Sox17 pathway for cardiac mesoderm formation in embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cells (Dayton, Ohio)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d7c92a675b6502a97a707b04cca69bc1"><gtr:id>d7c92a675b6502a97a707b04cca69bc1</gtr:id><gtr:otherNames>Liu Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1066-5099</gtr:issn><gtr:outcomeId>pm_13314_24_24585688</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0901467</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>DD81206B-5EB4-4BCC-AEF7-808A64606E0E</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>5.2  Cellular and gene therapies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>